Abiraterone Helps Improve Outcomes in Metastatic PCa - Renal and Urology News
Links shared publicly online about this topic.
- 135total visits
Abiraterone Helps Improve Outcomes in Metastatic PCa - Renal and Urology News
Abiraterone acetate (Zytiga) plus prednisone significantly improves survival in men with metastatic castration-resistant prostate cancer who have undergone chemotherapy, according to findings reported in The New England Journal of Medicine (2011;364:1995-2005)
View full resource at renalandurologynews.com
Tags: Prostate Cancer, Kidney Health, Urinary System, Prostate, Men's Health, Prednisone, Urology, News
Most Recently Shared on July 19, 2011 at 1:26 pm By:
Abiraterone Helps Improve Outcomes in Metastatic PCa: Abiraterone acetate (Zytiga) plus prednisone significantly... http://bit.ly/qJNaLV
Advertisement
